Want to join the conversation?
$JNJ 2Q15 Call – Dominic, CFO: On operational basis, excluding impact of acquisitions, divestitures & impact of Hep C products, sales were up 5%; & adjusted net earnings of $4.8Bil, down 6% vs. 2Q14. Adjusted EPS of $1.71 versus $1.78 a year ago, down approx. 4%.Excluding net impact of currency translation, operational EPS was $1.90, or up 6.7%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?